Missouri Avandia Heart Attack Lawyers
Avandia
Avandia (rosiglitazone), manufactured by GlaxoSmithKline, is part of a class of drugs approved by the FDA in 1998 to treat type 2 diabetes. Avandia is designed to help control blood sugar levels. GlaxoSmithKline failed to warn of Avandia's significant risk of cardiac problems.
Avandia's cardiovascular problems have been the subject of concern since May 2007, when an analysis of 42 clinical trails published by the Cleveland Clinic showed that patients taking the drug had a 43-percent higher risk of having a heart attack. In November 2007, the FDA required a black box warning detailing Avandia's link with myocardial ischemia.
A Senate Finance Committee report released in February 2010 found that GlaxoSmithKline not only knew about this drug's heart attack risks as early as 1999, but purposefully withheld such information from the public. According to the Senate report, the FDA advocated that Avandia be removed from the market as early as 2007 based upon reports of over 500 heart attacks and 300 cases of heart failure. In July 2007, the FDA revealed that it believed Avandia was responsible for an estimated 83,000 heart attacks.
Consulting an Avandia Attorney
If you or a loved one have suffered from a heart attack or heart failure while taking Avandia, the pharmaceutical liability attorneys at Page Law can help. Contact us online for a free evaluation of your case, or call us at (314) 322-8515.
